Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability

NGAL (Neutrophil Gelatinase-Associated Lipocalin) has emerged as a new biomarker for the identification of acute kidney injury. Reliable clinical evaluations require a simple, robust test method for NGAL, and knowledge of specimen handling and specimen stability characteristics. We evaluated the per...

Full description

Saved in:
Bibliographic Details
Published inClinical biochemistry Vol. 43; no. 6; pp. 615 - 620
Main Authors Grenier, Frank C., Ali, Salman, Syed, Hina, Workman, Ryan, Martens, Frans, Liao, Ming, Wang, Y., Wong, Pui-Yuen
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.04.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:NGAL (Neutrophil Gelatinase-Associated Lipocalin) has emerged as a new biomarker for the identification of acute kidney injury. Reliable clinical evaluations require a simple, robust test method for NGAL, and knowledge of specimen handling and specimen stability characteristics. We evaluated the performance of a new urine NGAL assay on the ARCHITECT analyzer. Assay performance characteristics were evaluated using standard protocols. Urine specimen storage requirements were determined and biological variability was assessed in a self-declared apparently healthy population. Assay performance data showed good precision, sensitivity and lot-to-lot reproducibility. There was good short term 2–8 °C sample stability, however, long term storage samples must be kept at − 70 °C or colder. The largest variance component in a biological variance study was within-day. The ARCHITECT NGAL assay proved to be a precise and reproducible assay for the determination of urine NGAL.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:0009-9120
1873-2933
1873-2933
DOI:10.1016/j.clinbiochem.2009.12.008